The global Allogenic Stem Cell Therapy Market is expected to reach USD 9.24 Billion in 2028 and register a steady revenue CAGR of 5.6% over the forecast period, according to latest report published by Reports and Data. Key factors driving global market revenue growth include increasing GMP (Good Manufacturing Practice) certification approvals for cell therapy manufacturing, rising awareness about stem cell therapies, and increasing funds by public and private sectors.
Cellular therapy is a transplantation process carried out by grafting or injecting viable cells into the donor’s body to replace or repair damaged tissues and cells that cannot be replenished by healthy cells. This therapy is widely used in treating various health conditions such as spinal cord injuries, schizophrenia, Alzheimer’s, stroke, urinary problems, head injuries, stroke, and infectious diseases, among others. Factors such as rapid increase in the number of clinical trials, improving healthcare facilities, rising disposable income, and healthcare expenditure, and high adoption of human cells for cell therapy research are boosting market revenue growth. In addition, increasing focus on commercializing stem cell treatments and increasing investments to develop enhanced and effective therapies are expected to boost market growth going ahead.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @https://www.reportsanddata.com/sample-enquiry-form/3269
Some key highlights of the report:
- Among the therapeutic area, the malignancies segment accounted for higher revenue share between 2021 and 2028 owing to factors such as rising prevalence of various types of cancer, rapid advancements in cell-based therapies, increasing cases of cancer relapse, and increasing usage of cell therapies for cancer treatment.
- Based on therapy type, the allogenic therapy is expected to account for significantly larger revenue share over the forecast period increasing prevalence of various types of cancer, and chronic disorders, rising incidence of cancer relapse, and increasing investments in RD activities.
- Based on cell type, the stem cell segment is expected to account for largest revenue share during the forecast period. This can be attributed to factors such as rising prevalence of chronic diseases, increasing research activities on stem cell treatment, and increasing stem cell banks across the globe.
- Based on end use, the hospitals clinics segment is expected to account for largest revenue share throughout the forecast period owing to increasing number of patients suffering from various chronic diseases, expanding healthcare budget, and easy access to latest cell therapies.
- The Allogenic Stem Cell Therapy Market in North America is expected to account for largest revenue share between 2021 and 2028 owing to factors such as high prevalence of various cardiovascular, neurological diseases, cancer, presence of well-developed healthcare and research facilities, and availability of advanced cell therapies. In addition, presence of key market players, rising investments in RD activities, and increasing demand for regenerative medicine are other factors driving North America market growth.
- Asia Pacific market is expected to register fastest revenue CAGR over the forecast period. Rapid revenue growth is attributed to factors such as growing geriatric population, high prevalence of chronic illnesses, and rising public awareness about cell therapies. Moreover, increasing adoption of regenerative medicine, increasing investments in research development activities, and availability of research approvals to develop effective cell therapies, treatment and products are factors driving market growth in Asia Pacific.
- Kolon TissueGene, Inc., Anterogen Co., Ltd., Inc., JCR Pharmaceuticals Co., Ltd., Castle Creek Biosciences, Inc., Mesoblast Ltd., Medipost Co. Ltd., Stemedica Cell Technologies, Inc., Osiris Therapeutics, Inc., PHARMICELL Co., Ltd., Holostem Terapie Avanzate S.r.l., Tameika Cell Technologies, Inc., Cells for Cells, NuVasive, Inc., Vericel Corporation, Celgene Corporation, Thermo Fisher Scientific Inc., Merck KGaA, and Danaher Corporation are key players profiled in the global market report.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.reportsanddata.com/report-detail/cell-therapy-market
For the purpose of this report, Reports and Data has segmented the global Allogenic Stem Cell Therapy Market based on therapy type, therapeutic area, cell type, end use, and region:
Therapy Type Outlook (Revenue, USD Billion; 2018-2028)
- Allogenic Stem Cell Therapy
- Autologous Stem Cell Therapy
Therapeutic Area Outlook (Revenue, USD Billion; 2018-2028)
- Malignancies
- Autoimmune Disorders
- Musculoskeletal Disorders
- Dermatology
- Others
Cell Type Outlook (Revenue, USD Billion; 2018-2028)
- Stem Cells
- Bone Marrow
- Umbilical Cord derived
- Adipose derived Stem Cells
- Others
- Non-Stem Cells
End-Use Outlook (Revenue, USD Billion; 2018-2028)
- Hospitals Clinics
- Regenerative Medicine Centers
- Academic Research Institutes
Regional Outlook (Revenue, USD Billion, 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Request a customization on the report @https://www.reportsanddata.com/request-customization-form/3269
Growing popularity of over-the-counter medications driving market growth
Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.
Restriction on product launches and RD activities to hamper market growth
Imposition of strict government regulations and shortage of funds have put a halt on the product launches and RD activities and are expected to restrain market growth over the forecast period. In addition, launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering market growth.
Press Release Available @https://www.reportsanddata.com/press-release/global-cell-therapy-market
Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.
Explore More Industry Research by Reports and Data:
Interstitial Cystitis Market @ https://www.biospace.com/article/interstitial-cystitis-market-growth-by-2030-increasing-prevalence-of-autoimmune-diseases-and-rising-women-population-across-the-globe-is-a-major-factor-driving-industry-revenue-growth/
Polycarbonate Panels Market @ https://www.biospace.com/article/polycarbonate-panels-market-revenue-is-expected-to-register-a-cagr-of-4-6-percent-between-2022-and-2030/
Myelodysplastic Syndrome Disease Market @ https://www.biospace.com/article/asia-pacific-market-is-predicted-to-increase-significantly-in-terms-of-cagr-in-the-global-myelodysplastic-syndrome-disease-market/
Traumatic Brain Injury Treatment Market @ https://www.biospace.com/article/north-america-dominated-the-traumatic-brain-injury-treatment-market-and-is-again-expected-to-grow-throughout-the-projected-period-2022-2030/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/video
